Literature DB >> 25172771

Molecular mimicry and clonal deletion: A fresh look.

Noel R Rose1.   

Abstract

In this article, I trace the historic background of clonal deletion and molecular mimicry, two major pillars underlying our present understanding of autoimmunity and autoimmune disease. Clonal deletion originated as a critical element of the clonal selection theory of antibody formation in order to explain tolerance of self. If we did have complete clonal deletion, there would be major voids, the infamous "black holes", in our immune repertoire. For comprehensive, protective adaptive immunity, full deletion is necessarily a rare event. Molecular mimicry, the sharing of epitopes among self and non-self antigens, is extraordinary common and provides the evidence that complete deletion of self-reactive clones is rare. If molecular mimicry were not common, protective adaptive immunity could not be all-encompassing. By taking a fresh look at these two processes together we can envision their evolutionary basis and understand the need for regulatory devices to prevent molecular mimicry from progressing to autoimmune disease.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Adaptive immunity; Autoimmunity; Clonal deletion; Immunoregulation; Molecular mimicry

Mesh:

Substances:

Year:  2014        PMID: 25172771      PMCID: PMC4344433          DOI: 10.1016/j.jtbi.2014.08.034

Source DB:  PubMed          Journal:  J Theor Biol        ISSN: 0022-5193            Impact factor:   2.691


  70 in total

Review 1.  Molecular mimicry: a critical look at exemplary instances in human diseases.

Authors:  N R Rose; I R Mackay
Journal:  Cell Mol Life Sci       Date:  2000-04       Impact factor: 9.261

Review 2.  Intrathymic and extrathymic clonal deletion of T cells.

Authors:  J Sprent; S R Webb
Journal:  Curr Opin Immunol       Date:  1995-04       Impact factor: 7.486

3.  Murine thyroiditis induced by neonatal thymectomy.

Authors:  Y Nishizuka; Y Tanaka; T Sakakura; A Kojima
Journal:  Experientia       Date:  1973-11-15

Review 4.  The genetic lesions of autoimmunity.

Authors:  N R Rose; Y C Kong; R S Sundick
Journal:  Clin Exp Immunol       Date:  1980-03       Impact factor: 4.330

5.  Suppression of ongoing experimental autoimmune myasthenia gravis by transfer of RelB-silenced bone marrow dentritic cells is associated with a change from a T helper Th17/Th1 to a Th2 and FoxP3+ regulatory T-cell profile.

Authors:  Huan Yang; Yong Zhang; Minghua Wu; Jing Li; Wenbin Zhou; Guiyuan Li; Xiaoling Li; Bo Xiao; Premkumar Christadoss
Journal:  Inflamm Res       Date:  2009-09-19       Impact factor: 4.575

6.  T-cell tolerance: exposure to virus in utero does not cause a permanent deletion of specific T cells.

Authors:  B D Jamieson; R Ahmed
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

7.  Pituitary expression of CTLA-4 mediates hypophysitis secondary to administration of CTLA-4 blocking antibody.

Authors:  Shintaro Iwama; Alessandra De Remigis; Margaret K Callahan; Susan F Slovin; Jedd D Wolchok; Patrizio Caturegli
Journal:  Sci Transl Med       Date:  2014-04-02       Impact factor: 17.956

Review 8.  Molecular mimicry as a mechanism of autoimmune disease.

Authors:  Matthew F Cusick; Jane E Libbey; Robert S Fujinami
Journal:  Clin Rev Allergy Immunol       Date:  2012-02       Impact factor: 8.667

9.  Immune privilege and the philosophy of immunology.

Authors:  Joan Stein-Streilein; Rachel R Caspi
Journal:  Front Immunol       Date:  2014-03-19       Impact factor: 7.561

Review 10.  Molecular mimicry and immune-mediated diseases.

Authors:  M B Oldstone
Journal:  FASEB J       Date:  1998-10       Impact factor: 5.191

View more
  9 in total

Review 1.  Molecular mimicry, genetic homology, and gene sharing proteomic "molecular fingerprints" using an EBV (Epstein-Barr virus)-derived microarray as a potential diagnostic method in autoimmune disease.

Authors:  David H Dreyfus; Antonella Farina; Giuseppina Alessandra Farina
Journal:  Immunol Res       Date:  2018-12       Impact factor: 2.829

2.  Differences in Self-Recognition between Secreted Antibody and Membrane-Bound B Cell Antigen Receptor.

Authors:  Joseena Iype; Moumita Datta; Ahmad Khadour; Rudolf Übelhart; Antonella Nicolò; Tim Rollenske; Marcus Dühren-von Minden; Hedda Wardemann; Palash C Maity; Hassan Jumaa
Journal:  J Immunol       Date:  2019-01-25       Impact factor: 5.422

Review 3.  Gene sharing between Epstein-Barr virus and human immune response genes.

Authors:  David H Dreyfus
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

Review 4.  Antinuclear antibodies in autoimmune and allergic diseases.

Authors:  Bogna Grygiel-Górniak; Natalia Rogacka; Michał Rogacki; Mariusz Puszczewicz
Journal:  Reumatologia       Date:  2017-12-30

5.  An Atypical Presentation of Pediatric Acute Neuropsychiatric Syndrome Responding to Plasmapheresis Treatment.

Authors:  Drew H Barzman; Hannah Jackson; Umesh Singh; Marcus Griffey; Michael Sorter; Jonathan A Bernstein
Journal:  Case Rep Psychiatry       Date:  2018-06-28

Review 6.  The Enigmatic Role of Viruses in Multiple Sclerosis: Molecular Mimicry or Disturbed Immune Surveillance?

Authors:  Jens Geginat; Moira Paroni; Massimiliano Pagani; Daniela Galimberti; Raffaele De Francesco; Elio Scarpini; Sergio Abrignani
Journal:  Trends Immunol       Date:  2017-05-23       Impact factor: 16.687

7.  Acute pancreatitis soon after COVID-19 vaccination: A case report.

Authors:  Sotaro Ozaka; Takamoto Kodera; Shimpei Ariki; Takashi Kobayashi; Kazunari Murakami
Journal:  Medicine (Baltimore)       Date:  2022-01-14       Impact factor: 1.817

8.  Comparison of Burnet's clonal selection theory with tumor cell-clone development.

Authors:  Borros Arneth
Journal:  Theranostics       Date:  2018-05-23       Impact factor: 11.556

Review 9.  Examining pathogenic concepts of autoimmune hepatitis for cues to future investigations and interventions.

Authors:  Albert J Czaja
Journal:  World J Gastroenterol       Date:  2019-12-07       Impact factor: 5.742

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.